Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial.
Abderrahim OulhajFaisal AzizAbubaker SulimanKathrin EllerRachid BentoumiJohn B BuseWael Al MahmeedDirk von LewinskiRuth L ColemanRury R HolmanHarald SourijPublished in: Diabetes, obesity & metabolism (2024)
eGFR trajectories over time significantly predict incident MACE/hHF events in people with type 2 diabetes with and without existing CVD, with a higher hazard ratio for MACE/hHF in the latter group.
Keyphrases
- cardiovascular events
- heart failure
- cardiovascular disease
- coronary artery disease
- small cell lung cancer
- epidermal growth factor receptor
- study protocol
- phase iii
- tyrosine kinase
- depressive symptoms
- clinical trial
- phase ii
- left ventricular
- randomized controlled trial
- cardiac resynchronization therapy
- atrial fibrillation
- type diabetes
- adverse drug